BioArctic AB (publ) (FRA:B9A)
Germany · Delayed Price · Currency is EUR 31.62
+1.34 (4.43%)
At close: Jan 28, 2026
BioArctic AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,916 | 257.35 | 616 | 228.29 | 23.15 | 62.35 |
Other Revenue | - | - | - | 1.14 | 2.52 | 2.86 |
| 1,916 | 257.35 | 616 | 229.43 | 25.66 | 65.21 | |
Revenue Growth (YoY) | 1046.52% | -58.22% | 168.49% | 794.02% | -60.64% | -76.95% |
Cost of Revenue | 56 | 26.98 | 14.99 | 74.33 | 55.07 | 50.24 |
Gross Profit | 1,860 | 230.37 | 601.01 | 155.11 | -29.4 | 14.96 |
Selling, General & Admin | 191.88 | 148.84 | 172.18 | 148.67 | 97.35 | 86.35 |
Research & Development | 388.34 | 311.15 | 172.14 | - | - | - |
Other Operating Expenses | -4.25 | - | -0.27 | -0.25 | -0.01 | -0.08 |
Operating Expenses | 575.97 | 459.99 | 344.05 | 163.04 | 110.45 | 97.28 |
Operating Income | 1,284 | -229.62 | 256.96 | -7.94 | -139.85 | -82.32 |
Interest Expense | -31.78 | - | -0.33 | -0.56 | -0.84 | -0.98 |
Interest & Investment Income | 34.17 | 40.85 | 34.23 | 2.54 | - | 0.01 |
Currency Exchange Gain (Loss) | -114.13 | -0.75 | -14.32 | -5.01 | 0.33 | -3.07 |
Other Non Operating Income (Expenses) | 0 | 0 | -0.05 | -0.19 | -0.15 | -0.11 |
EBT Excluding Unusual Items | 1,173 | -189.52 | 276.49 | -11.17 | -140.5 | -86.48 |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.01 | -0.21 |
Pretax Income | 1,173 | -189.52 | 276.49 | -11.17 | -140.51 | -86.69 |
Income Tax Expense | 172.92 | -12.44 | 47.24 | 0.01 | -20.72 | -18.17 |
Net Income to Company | - | -177.08 | 229.25 | -11.18 | -119.79 | -68.52 |
Net Income | 999.69 | -177.08 | 229.25 | -11.18 | -119.79 | -68.52 |
Net Income to Common | 999.69 | -177.08 | 229.25 | -11.18 | -119.79 | -68.52 |
Shares Outstanding (Basic) | 89 | 88 | 88 | 88 | 88 | 88 |
Shares Outstanding (Diluted) | 89 | 89 | 88 | 89 | 88 | 88 |
Shares Change (YoY) | 0.60% | 0.04% | -0.22% | 0.71% | - | - |
EPS (Basic) | 11.29 | -2.00 | 2.60 | -0.13 | -1.36 | -0.78 |
EPS (Diluted) | 11.25 | -2.00 | 2.59 | -0.13 | -1.36 | -0.78 |
Free Cash Flow | 1,064 | -342.97 | 302.25 | -44.38 | -144.84 | -104.81 |
Free Cash Flow Per Share | 11.97 | -3.87 | 3.42 | -0.50 | -1.65 | -1.19 |
Gross Margin | 97.08% | 89.52% | 97.57% | 67.60% | -114.58% | 22.95% |
Operating Margin | 67.02% | -89.22% | 41.71% | -3.46% | -544.96% | -126.24% |
Profit Margin | 52.17% | -68.81% | 37.22% | -4.87% | -466.78% | -105.08% |
Free Cash Flow Margin | 55.51% | -133.27% | 49.07% | -19.35% | -564.40% | -160.74% |
EBITDA | - | -211.19 | 275.39 | -1.87 | -134.72 | -78.49 |
EBITDA Margin | - | -82.06% | 44.71% | -0.82% | - | -120.37% |
D&A For EBITDA | - | 18.43 | 18.43 | 6.07 | 5.13 | 3.83 |
EBIT | 1,284 | -229.62 | 256.96 | -7.94 | -139.85 | -82.32 |
EBIT Margin | 67.02% | -89.22% | 41.71% | -3.46% | - | -126.24% |
Effective Tax Rate | 14.75% | - | 17.09% | - | - | - |
Revenue as Reported | - | - | - | -228.63 | 26.69 | 65.94 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.